|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae显示文摘 | Pawlak J Saravolatz L | 1999 | J Antimicrob Chemother1999，43，： | 1 |
| 2 | Methicillinre- sistant Staphylococcus aureus, epidemiologic observations dur- ing a community-acquired outbreak显示文摘 | Saravolatz LD Markowitz M Artfing L | 1982 | Ann Intern Med1982，96，1： | 1 |
| 3 | In-vitro activity of 29 antimicrobial agents against penicillin resistant and intermediate isolates of Streptococcus pneumoniae显示文摘 | Manzor O Pawlak J Saravolatz L | 1999 | Antimicrob Chemother1999，43，： | 1 |
| 4 | Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae显示文摘 | Saravolatz L Manzor O Check C | 2001 | J Antimicrob Chemother2001，47，6： | 1 |
| 5 | Voricona-zole: A New Triazole Antifungal Agent 显示文摘 | Saravolatz L D Johnson L B Kauffman C A | 2003 | Clinical In-fectious Diseases2003，36，5： | 1 |
| 6 | Rilpivirine: A new non-nu- cleoside reverse transcriptase inhibitor 显示文摘 | SHARMA M SARAVOLATZ L D | 2012 | J Antimicrob Che- moth2012，55，2： | 1 |
| 7 | In vitro activity of ceftaroline against community-associated methicillin-resistant,vancomycin- intermediate, vancomycin-resistant, and daptomycin-nonsuscep- tible Staphylococcus aureus isolates 显示文摘 | Saravolatz L Pawlak J Johnson L | 2010 | Antimicrob Agents Che- mother2010，54，7： | 1 |
| 8 | In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycinnonsusceptible Staphylococcus aureus isolates显示文摘 | SARAVOLATZ L PAWLAK J JOHNSON L | 2010 | Antimicrob Agents Chemother2010，54，7： | 1 |
| 9 | Trimethoprim sulfamethoxazole compared with vancomycin for treatment of Staphylococcus aureus infection 显示文摘 | Markowitz N Quinn E L Saravolatz L D | 1992 | Ann Intern Med1992，117，： | 1 |
| 10 | In vitro activity of LTX-109 a syntheticantimicrobial peptide against MRSA,VISA,VRSA,daptomycinnon-susceptible staphylococcus aureus(DNSSA)and linezolidnon-susceptible SA(LNSSA)显示文摘 | Saravolatz LD Pawlak J Johnson L | 2012 | Antimicrob Agents Chemother2012，56，8： | 1 |
| 11 | Antimicrobial activity of mo-xifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae显示文摘 | Saravolatz L Manzor O Check C | 2001 | J Antimicrob Chemother2001，47，： | 1 |
| 12 | Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae显示文摘 | Saravolatz L Manzor O Check C | 2001 | J Antimicrob Chemother2001，47，6： | 1 |
| 13 | In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin intermediate, vancomyein-resistant, and daptomycin-nonsuscepti- ble Staphylococcus aureus isolates显示文摘 | Saravolatz L Pawlak J Johnson L | 2010 | Antimicrob Agents Che mother2010，54，7： | 1 |
| 14 | Methicillin-re- sistant Staphylococcus aureus epidemiologie observations dur- ing a community-acquired outbreak 显示文摘 | Saravolatz L D Markowitz N: Arking L | 1982 | Annals of InternalMedicine1982，96，1： | 1 |
| 15 | In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus 显示文摘 | Saravolatz LD Pawlak J Johnson L | 2012 | Antimicrob Agents Chemother2012，56，8： | 1 |
| 16 | Minocycline inhibits caspase activation and reactivation,increases the ratio of XIAP to smac/DIABLO,and reduces the mitochondrial leakage of cYtochrome C and smac/DIABLO显示文摘 | Scarabelli IM Stephanou A Pasini E Gitti G Townsend P Lawrence K Chen-Scarabelli C Saravolatz L Latchman D Knight R Gardin J | | 0，，： | 1 |
| 17 | lnvitroactivity of 29 antimicrobial agents against penicillin resistant and intermediate isolates of Streptococcus pneumoniae 显示文摘 | Manzor O Pawlak J Saravolatz L | 1999 | J A ntimicrob Chemother1999，43，： | 1 |
| 18 | Nitazoxanide: a new thiazolide antiparasitic agent显示文摘 | Fox L M Saravolatz L D | 2005 | Clin Infect Dis2005，40，8： | 1 |
| 19 | In vitro activity of ceftaroline against community-associated methicillin- resistant, vancomycin-intermediate, vancomycinresistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates显示文摘 | Saravolatz L Pawlak J Johnson L | 2010 | Antimicrob Agents Chemother2010，54，7： | 1 |
| 20 | Nitazoxanide: a new thiazolid antiparasitic agent 显示文摘 | FOX L M SARAVOLATZ L D | 2005 | Clin Infect Dis2005，40，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员